Outcomes** · people with Acute Respiratory Distress Syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality (at 30 days or until hospital discharge) · people with Acute Respiratory Distress Syndrome
It is very uncertain whether high‐frequency oscillation changes mortality (at 30 days or until hospital discharge) compared with conventional ventilation (very low certainty).
1 finding from 1 review
Mortality (at 6 months) · people with Acute Respiratory Distress Syndrome
It is very uncertain whether high‐frequency oscillation changes mortality (at 6 months) compared with conventional ventilation (very low certainty).
1 finding from 1 review
Treatment failure · people with Acute Respiratory Distress Syndrome
It is very uncertain whether high‐frequency oscillation changes treatment failure compared with conventional ventilation (very low certainty).
1 finding from 1 review
Duration of mechanical ventilation · people with Acute Respiratory Distress Syndrome
1 finding from 1 review
Barotrauma · people with Acute Respiratory Distress Syndrome
It is very uncertain whether high‐frequency oscillation changes barotrauma compared with conventional ventilation (very low certainty).
1 finding from 1 review
Hypotension · people with Acute Respiratory Distress Syndrome
It is very uncertain whether high‐frequency oscillation changes hypotension compared with conventional ventilation (very low certainty).
1 finding from 1 review
Time to loss of eyelash reflex · Patients undergoing inhalational induction of anaesthesia
1 finding from 1 review
Cough · Patients undergoing inhalational induction of anaesthesia
High initial concentration showed no clear difference in cough compared with low initial concentration (low certainty).
1 finding from 1 review
Laryngospasm · Patients undergoing inhalational induction of anaesthesia
High initial concentration showed no clear difference in laryngospasm compared with low initial concentration (low certainty).
1 finding from 1 review
Breath holding · Patients undergoing inhalational induction of anaesthesia
High initial concentration showed no clear difference in breath holding compared with low initial concentration (low certainty).
1 finding from 1 review
Apneoa · Patients undergoing inhalational induction of anaesthesia
High initial concentration may leads to higher apneoa compared with low initial concentration (low certainty).
1 finding from 1 review
Patient movement · Patients undergoing inhalational induction of anaesthesia
High initial concentration showed no clear difference in patient movement compared with low initial concentration (low certainty).
1 finding from 1 review
Bradycardia · Patients undergoing inhalational induction of anaesthesia
High initial concentration showed no clear difference in bradycardia compared with low initial concentration (low certainty).
1 finding from 1 review
Change in Mutans streptococci (MS) and Lactobacilli in saliva · Schoolchildren (6-9 years), high caries risk
The single stevia trial (Cocco 2019) reported a significant reduction in salivary Mutans streptococci and lactobacilli, but gave no effect size and was not GRADE-rated.
1 finding from 1 review
Clinical Effects of Sugar Substitutes on Cariogenic Bacteria: A Systematic Review and Meta-Analysis. 2024 All outcomes42 days · Schoolchildren in Italy, high caries risk; sweetener delivered as a daily snack · Single study (Cocco 2019); not pooled
Cocco 2019 (the only high-intensity sweetener trial): the stevia snack showed a significant decrease in MS (P < .01) and in lactobacilli (P = .03) versus baseline, whereas the white-sugar snack showed no significant…
1 study · 271 participants
GRADE not reported
Total mortalitya · people with antiphospholipid syndrome and a history of stroke or thromboembolic events
High‐dose VKA showed no clear difference in all‐cause mortalitya compared with standard‐dose VKA (low certainty).
1 finding from 1 review
Strokea · people with antiphospholipid syndrome and a history of stroke or thromboembolic events
High‐dose VKA showed no clear difference in strokea compared with standard‐dose VKA (low certainty).
1 finding from 1 review
Any bleedingb · people with antiphospholipid syndrome and a history of stroke or thromboembolic events
High‐dose VKA showed no clear difference in any bleedingb compared with standard‐dose VKA (low certainty).
1 finding from 1 review
Adverse events · people with antiphospholipid syndrome and a history of stroke or thromboembolic events
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thromboembolic events · people with antiphospholipid syndrome and a history of stroke or thromboembolic events
High‐dose VKA showed no clear difference in any thromboembolic event compared with standard‐dose VKA (low certainty).
1 finding from 1 review